Global POCT Diagnostic Analyzer Market Growth (Status and Outlook) 2023-2029

Global POCT Diagnostic Analyzer Market Growth (Status and Outlook) 2023-2029

Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings.

LPI (LP Information)' newest research report, the “POCT Diagnostic Analyzer Industry Forecast” looks at past sales and reviews total world POCT Diagnostic Analyzer sales in 2022, providing a comprehensive analysis by region and market sector of projected POCT Diagnostic Analyzer sales for 2023 through 2029. With POCT Diagnostic Analyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POCT Diagnostic Analyzer industry.

This Insight Report provides a comprehensive analysis of the global POCT Diagnostic Analyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POCT Diagnostic Analyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POCT Diagnostic Analyzer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POCT Diagnostic Analyzer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POCT Diagnostic Analyzer.

The global POCT Diagnostic Analyzer market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for POCT Diagnostic Analyzer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for POCT Diagnostic Analyzer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for POCT Diagnostic Analyzer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key POCT Diagnostic Analyzer players cover Getein Biotech, Guangzhou Wondfo Biotech, EasyDiagnosis Biomedicine, Roche Holding AG, ABBOTT, Siemens Healthcare, BD, Quidel and Danaher Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of POCT Diagnostic Analyzer market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Urinalysis Analyzers
Blood Glucose Meter
Clinical Chemistry Analyzers
Blood Gas Analyzers
INR Test Meter
Cardiac Marker Analyzers
Electrolyte Analyzers
Hemoglobin Meter
Other

Segmentation by application
Hospital
Clinic
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Getein Biotech
Guangzhou Wondfo Biotech
EasyDiagnosis Biomedicine
Roche Holding AG
ABBOTT
Siemens Healthcare
BD
Quidel
Danaher Corp
Abaxis

Please note: The report will take approximately 2 business days to prepare and deliver.